Chemists react to new compounds in Chicago.
Service
R F
RF
D000893:Anti-Inflammatory Agents / Q000138:chemical synthesis*; D002384:Catalysis; D002626:Chemistry, Pharmaceutical / Q000379:methods*; D015195:Drug Design; D011108:Polymers; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000138:chemical synthesis / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis
D000893:Anti-Inflammatory Agents; D011108:Polymers; D014409:Tumor Necrosis Factor-alpha; D013792:Thalidomide